K2229548计算溶液所需的质量、体积或浓度。
为什么选择此级别
提供 ≥97% 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
储存与运输
避光,-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
质量文档
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
文献证明
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
概述
Information
CHIR-99021 (CT99021) HCl is hydrochloride of CHIR-99021, which is aGSK-3α/βinhibitor withIC50of 10 nM/6.7 nM; CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs Cdc2 and ERK2. CHIR-99021 is a potent pharmacological activators of theWnt/beta-cateninsignaling pathway. CHIR-99021 significantly rescues light-inducedautophagyand augments GR, RORα and autophagy-related proteins.
Targets
GSK-3β (Cell-free assay); GSK-3α (Cell-free assay) 6.7 nM; 10 nM
In vitro
CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. Furthermore, CHIR-99021 shows only weak binding to a panel of 22 pharmacologically relevant receptors and little inhibitory activity against a panel of 23 nonkinase enzymes. CHIR-99021 induces the activation of glycogen synthase (GS) in insulin receptor-expressing CHO-IR cells with EC50 of 0.763 μM. In addition to simulating the actions of insulin, inhibition of GSK-3 by CHIR-99021 (3 μM) increases free cytosolic β-catenin by 1.9-fold, mimicking the canonical Wnt signaling pathway in 3T3-L1 preadipocytes. During any of the first 3 days of differentiation, CHIR-99021 treatment inhibits the preadipocyte differentiation with IC50 of 0.3 μM by blocking induction of CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ). Unlike lithium chloride and AR-A014418, CHIR-99021 treatment does not reduce the viability of INS-1E cells even at high concentrations. Instead, CHIR-99021 robustly increases the rate of proliferation of INS-1E cells in a dose-dependent manner, and significantly inhibits INS-E cell death induced by high glucose and high palmitate in a concentration-dependent manner. CHIR-99021 promotes primary beta cell replication in isolated rat islets at concentrations as low as 1 μM, with 2-3 fold increase of cell replication at 5 μM of CHIR-99021 treatment.
In vivo
Oral administration of CHIR-99021 at 30 mg/kg enhances glucose metabolism in a rodent model of type 2 diabetes, with a maximal plasma glucose reduction of nearly 150 mg/dl 3-4 hours after administration, while plasma insulin remains at or below control levels. Oral administration of CHIR-99021 at 16 or 48 mg/kg 1 hour before oral glucose challenges in ZDF rats significantly improves glucose tolerance with 14% and 33% reduction in plasma glucose at 16 mg/kg and 48 mg/kg, respectively, and the higher dose of CHIR-99021 also reduces hyperglycemia before the oral glucose challenge. Administration of CHIR-99021 significantly augments hematopoietic repopulation in recipient mice transplanted with mouse or human hematopoietic stem cells (HSCs), suggesting that GSK-3 is a specific modulator of HSC activity.
Cell Research(from reference)
Cell lines：INS-1E
Concentrations：Dissolved in DMSO, final concentrations ~ 20 μM
Incubation Time：1, or 4 days
规格
英文别名
AS-19380 | CHIR 99021 hydrochloride | Laduviglusib (monohydrochloride) | CHIR-99021 (monohydrochloride) | s2924 | SCHEMBL17165152 | AC-33146 | 5AW8G37ZX5 | UNII-5AW8G37ZX5 | 6-((2-((4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)
规格或纯度
≥97%
英文名称
CHIR-99021 (CT99021) HCl
生化机理
CHIR-99021 (CT99021) HCl 是 CHIR-99021 的盐酸盐，它是一种 GSK-3α/β 抑制剂，IC50 为 10 nM/6.7 nM；CHIR-99021 对 GSK-3 的选择性是其最接近的同源物 Cdc2 和 ERK2 的 500 倍以上。CHIR-99021 是 Wnt/beta-catenin 信号通路的强效药理学激活剂。CHIR-99021 能明显缓解光诱导的自噬，并增强 GR、RORα 和自噬相关蛋白。
储存条件
避光,-20°C储存
运输条件
超低温运输
作用类型
抑制剂
纯度
≥97%
名称和识别符
PubChem SID
分子类型
小分子
IUPAC Name
6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile;hydrochloride
INCHI
1S/C22H18Cl2N8.ClH/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19;/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32);1H
InChi Key
SCQDMKUZHIGAIB-UHFFFAOYSA-N
Smiles
CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N.Cl
Isomeric SMILES
CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N.Cl
关联CAS
分子量
501.8
Reaxy-Rn
35509416
Reaxys-RN link address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=35509416&ln=
技术文档
高级数据
系统学分类
分类树（Taxonomy Tree）
| 界（kingdom) | 有机化合物 |
|---|---|
| 超类（Superclass) | 有机杂环化合物 |
| 类（Class) | 二嗪类 |
| 亚类（Subclass） | 嘧啶和嘧啶衍生物 |
| 中间层级节点（Intermediate Tree Nodes） | 暂无 |
| 直接上位类(Direct Parent) | 苯基嘧啶 |
| 其他上位类（Alternative Parents） | 二氯苯 3-吡啶腈 氨基嘧啶及其衍生物 氨基吡啶及其衍生物 咪唑内酰胺类 芳基氯化物 咪唑类 杂芳族化合物 腈类 氮杂环化合物 有机氯化物 盐酸盐 碳氢化合物衍生物 胺类 |
| 分子骨架（Molecular Framework) | 芳香族杂单环化合物 |
| 取代基（Substituents） | 1,3-二氯苯 - 3-吡啶甲腈 - 4-苯基嘧啶 - 氨基酸 - 氨基吡啶 - 氨基吡啶 - 芳香族杂单环化合物 - 芳基氯化物 - 芳基卤化物 - 氮杂环 - 吡唑 - 苯基化合物 - 碳腈 - 氯苯 - 氰化物 - 卤苯 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - 咪唑 - 咪唑内酰胺 - 单环苯基基团 - 氰基化合物 - 有机硝基化合物 - 有机氯化物 - 有机卤化物 - 有机氮化合物 - 吡啶 |
| 描述（Description） | 该化合物属于苯并嘧啶类有机化合物。这类多环芳烃化合物通过碳碳键或氰基键将苯环与嘧啶环相连。嘧啶为六元环结构，由四个碳原子及位于1位和3位的两个氮原子中心构成。 |
| 外部描述符（External Descriptors） | 暂无 |
三维结构
交互式化学结构模型
化学和物理性质
溶解性
Solubility (25°C) In vitro DMSO: 100 mg/mL (199.28 mM); Ethanol: 47 mg/mL (93.66 mM); Water: Insoluble;
敏感性
对光线敏感
分子量
501.800 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count
4
氢键受体数Hydrogen Bond Acceptor Count
7
可旋转键计数Rotatable Bond Count
7
精确质量Exact Mass
500.08 Da
单同位素质量Monoisotopic Mass
500.08 Da
拓扑极表面积Topological Polar Surface Area
115.000 Ų
重原子数Heavy Atom Count
33
形式电荷Formal Charge
0
复杂度Complexity
645.000
同位素原子数Isotope Atom Count
0
定义的原子立体中心计数Defined Atom Stereocenter Count
0
未定义的原子立体中心计数Undefined Atom Stereocenter Count
0
定义的键立体中心计数Defined Bond Stereocenter Count
0
未定义的键立体中心计数Undefined Bond Stereocenter Count
0
所有立体化学键的总数The total count of all stereochemical bonds
0
共价键合单元计数Covalently-Bonded Unit Count
2
安全和危险性（GHS）
信号词
警告
危险声明
H302: 吞食有害
H315: 引起皮肤刺激
H319: 引起严重眼睛刺激
H335: 可能引起呼吸道刺激
预防措施声明
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾
P305+P351+P338: 如进入眼睛：用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出，取出隐形眼镜。继续冲洗。
质检证书（CoA,COO,BSE/TSE 和分析图谱)
溶液计算器
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 保留所有权利。
危险品化学品经营许可证（带存储）